| MCVRX | VEVYX | MCVRX / VEVYX | |
| Total Expense Ratio | 1.24 | 0.66 | 188% |
| Annual Report Gross Expense Ratio | 1.25 | 0.66 | 189% |
| Fund Existence | 22 years | 13 years | - |
| Gain YTD | 4.896 | 1.716 | 285% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 1000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 16.8B | 16.4B | 102% |
| Annual Yield % from dividends | 0.61 | 1.05 | 58% |
| Returns for 1 year | -9.60 | -12.13 | 79% |
| Returns for 3 years | 12.69 | -0.47 | -2,679% |
| Returns for 5 years | 37.73 | 23.29 | 162% |
| Returns for 10 years | 74.52 | 51.15 | 146% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BBH | 189.00 | 1.94 | +1.04% |
| VanEck Biotech ETF | |||
| BDVG | 12.83 | 0.09 | +0.73% |
| iMGP Berkshire Dividend Growth ETF | |||
| RSDE | 21.56 | 0.12 | +0.55% |
| FT Vest U.S. Eq Eql Wght Buffr ETF - Dec | |||
| AFMC | 34.04 | 0.14 | +0.40% |
| First Trust Active Factor Mid Cap ETF | |||
| TSPA | 43.04 | 0.04 | +0.09% |
| T. Rowe Price US Equity Research ETF | |||